N@N

Alex Arfaei Maintained (ABBV) at Hold with Increased Target to $84 on, Nov 16th, 2017

Alex Arfaei of BMO Capital, Maintained "AbbVie Inc." (ABBV) at Hold with Increased Target from $66 to $84 on, Nov 16th, 2017.

Alex has made no other calls on ABBV in the last 4 months.

There are 7 other peers that have a rating on ABBV. Out of the 7 peers that are also analyzing ABBV, 3 agree with Alex's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Marc Goodman of "UBS" Maintained at Hold with Increased Target to $95 on, Friday, October 13th, 2017
• Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $90 on, Friday, October 13th, 2017
• Gregg Gilbert of "Deutsche Bank" Maintained at Hold with Increased Target to $66 on, Monday, July 17th, 2017

These are the ratings of the 4 analyists that currently disagree with Alex

---

• Geoffrey Porges of "Leerink Swann" Maintained at Buy with Decreased Target to $107 on, Monday, October 30th, 2017
• Steve Scala of "Cowen & Co." Upgraded from Hold to Buy on, Wednesday, October 11th, 2017
• Jeffrey Holford of "Jefferies" Maintained at Strong Buy with Increased Target to $107 on, Friday, September 15th, 2017
• Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $95 on, Thursday, August 17th, 2017